IGAN
Clinical trials for IGAN explained in plain language.
Never miss a new study
Get alerted when new IGAN trials appear
Sign up with your email to follow new studies for IGAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for kidney disease in early trial
Disease control Not yet recruitingThis study tests a new drug called FXS6837 for people with IgA nephropathy, a kidney disease. About 60 adults will receive either the drug or a placebo to see if it reduces protein in the urine, a sign of kidney damage. The goal is to control the disease and protect kidney functi…
Matched conditions: IGAN
Phase: PHASE2 • Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New pill aims to slow kidney disease in IgA nephropathy patients
Disease control Not yet recruitingThis study tests an experimental drug called HS-10542 in people with IgA nephropathy, a kidney disease that can lead to kidney failure. About 90 adults will receive either the drug or a placebo to see if it reduces protein in the urine, a sign of kidney damage. The goal is to con…
Matched conditions: IGAN
Phase: PHASE2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:55 UTC